GALNT11 as a new molecular marker in chronic lymphocytic leukemia

Gene

Volumn 533, Issue 1, 2014, Pages 270-279

  Libisch, M G ^a   Casas M ^b   Chiribao, M L ^a,c   Moreno, P ^a   Cayota, A ^a   Osinaga, E ^a,c   Oppezzo, P ^a,c   Robello, C ^a,c  

^a INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^b ASTRAZENECA   (United Kingdom)

^c DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

GalNAc T transferases; Molecular marker; O glycosylation; Tn antigen

Indexed keywords

BINDING PROTEIN; CD23 ANTIGEN; CD5 ANTIGEN; CD79B ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; LIPOPROTEIN LIPASE; MEMBRANE PROTEIN; MOLECULAR MARKER; N ACETYLGALACTOSAMINYLTRANSFERASE; PROTEIN GALNT11; TN ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELL DENSITY; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; GLYCOSYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTOSIS; MUTATIONAL ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

AA; AMINO ACID(S); BASE PAIR; BOVINE SERUM ALBUMIN; BP; BSA; CD19; CD3; CDNA; CHRONIC LYMPHOCYTIC LEUKEMIA; CLL; CLUSTER OF DIFFERENTIATION 19; CLUSTER OF DIFFERENTIATION 3; DNA COMPLEMENTARY TO RNA; FBS; FETAL BOVINE SERUM; GALNAC-T TRANSFERASES; GALNAC-TS; GALNT11; GAPDH; GENE THAT ENCODE GALNAC-T11; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE; IG; IGHV; IIF; IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION; IMMUNOGLOBULIN(S); INDIRECT IMMUNOFLUORESCENCE; ISOLECTIN B4 FROM VICIA VILLOSA; LIPOPROTEIN LIPASE; LPL; MAB; MMLV; MOLECULAR MARKER; MOLONEY MURINE LEUKEMIA VIRUS; MONOCLONAL ANTIBODY; MUT; MUTATED; O-GLYCOSYLATION; PA-GEL ELECTROPHORESIS; PAGE; PB; PBMCS; PBS; PCA; PEPTIDE COMPETITION ASSAY; PERIPHERAL BLOOD; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHOSPHATE-BUFFERED SALINE; QPCR; QUANTITATIVE REAL TIME PCR; RELATIVE EXPRESSION SOFTWARE TOOL; REST; SDS; SODIUM DODECYL SULFATE; TN ANTIGEN; UDP-N-ACETYL-Α-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; UM; UNMUTATED; VVB4; ZAP-70; ZETA-ASSOCIATED PROTEIN 70;

BASE SEQUENCE; DNA PRIMERS; HUMANS; JURKAT CELLS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; N-ACETYLGALACTOSAMINYLTRANSFERASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84887220004     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.09.052     Document Type: Article

References (51)

1. Aller C.T., Kucuk O., Springer G.F., Gilman-Sachs A. Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells. Am. J. Hematol. 1996, 52:29-38.
2. Antonopoulos A., Demotte N., Stroobant V., Haslam S.M., van der Bruggen P., Dell A. Loss of effector function of human cytolytic T lymphocytes is accompanied by major alterations in N- and O-glycosylation. J. Biol. Chem. 2012, 287:11240-11251.
3. Bennett E.P., Mandel U., Clausen H., Gerken T.A., Fritz T.A., Tabak L.A. Control of mucin-type O-glycosylation - a classification of the polypeptide GalNAc-transferase gene family. Glycobiology 2012, 22:736-756.
4. Berois N., et al. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma. Clin. Chem. 2006, 52:1701-1712.
5. Berois N., et al. GALNT9 gene expression is a prognostic marker in neuroblastoma patients. Clin. Chem. 2013, 59:225-233.
6. Binet J.L., et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981, 48:198-206.
7. Blixt O., et al. Analysis of Tn-antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells. Glycobiology 2012, 22:529-542.
8. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1999, 1473:67-95.
9. Brooks S.A., Carter T.M., Bennett E.P., Clausen H., Mandel U. Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer. Acta Histochem. 2007, 109:273-284.
10. Ching C.K., Holmes S.W., Holmes G.K., Long R.G. Comparison of two sialosyl-Tn binding monoclonal antibodies (MLS102 and B72.3) in detecting pancreatic cancer. Gut 1993, 34:1722-1725.
11. Damle R.N., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-1847.
12. Dighiero G., Hamblin T.J. Chronic lymphocytic leukaemia. Lancet 2008, 371:1017-1029.
13. Freire T., Berois N., Sonora C., Varangot M., Barrios E., Osinaga E. UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of bone marrow-disseminated breast cancer cells. Int. J. Cancer 2006, 119:1383-1388.
14. Gomes J., et al. Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma. J. Histochem. Cytochem. 2009, 57:79-86.
15. Gu C., et al. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. Br. J. Cancer 2004, 90:436-442.
16. Hagen F.K., Ten Hagen K.G., Beres T.M., Balys M.M., VanWuyckhuyse B.C., Tabak L.A. cDNA cloning and expression of a novel UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. J. Biol. Chem. 1997, 272:13843-13848.
17. Hallek M. Prognostic factors in chronic lymphocytic leukemia. Ann. Oncol. 2008, 19(Suppl. 4):iv51-iv53.
18. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94:1848-1854.
19. Inoue T., et al. Expression of GalNAc-T3 and its relationships with clinicopathological factors in 61 extrahepatic bile duct carcinomas analyzed using stepwise sections - special reference to its association with lymph node metastases. Mod. Pathol. 2007, 20:267-276.
20. Ishikawa M., Kitayama J., Nariko H., Kohno K., Nagawa H. The expression pattern of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 in early gastric carcinoma. J. Surg. Oncol. 2004, 86:28-33.
21. Iwasaki H., et al. Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2. J. Biol. Chem. 2003, 278:5613-5621.
22. Kohsaki T., et al. Expression of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase isozymes T1 and T2 in human colorectal cancer. J. Gastroenterol. 2000, 35:840-848.
23. Landers K.A., et al. Use of multiple biomarkers for a molecular diagnosis of prostate cancer. Int. J. Cancer 2005, 114:950-956.
24. Li Q., Anver M.R., Butcher D.O., Gildersleeve J.C. Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines. Mol. Cancer Ther. 2009, 8:971-979.
25. Mandel U., et al. Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family. Glycobiology 1999, 9:43-52.
26. Miyahara N., et al. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder. Clin. Cancer Res. 2004, 10:2090-2099.
27. Moreno C., Montserrat E. New prognostic markers in chronic lymphocytic leukemia. Blood Rev. 2008, 22:211-219.
28. Muroi K., et al. Expression of sialosyl-Tn in colony-forming unit-erythroid, erythroblasts, B cells, and a subset of CD4+ cells. Blood 1994, 83:84-91.
29. Nakada H., et al. Expression of the Tn antigen on T-lymphoid cell line Jurkat. Biochem. Biophys. Res. Commun. 1991, 179:762-767.
30. Oppezzo P., et al. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 2005, 106:650-657.
31. Osinaga E., et al. Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy. FEBS Lett. 2000, 469:24-28.
32. Park J.H., et al. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Cancer Res. 2010, 70:2759-2769.
33. Patani N., Jiang W., Mokbel K. Prognostic utility of glycosyltransferase expression in breast cancer. Cancer Genomics Proteomics 2008, 5:333-340.
34. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
35. Piller F., Piller V., Fox R.I., Fukuda M. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J. Biol. Chem. 1988, 263:15146-15150.
36. Qiu H., Guo X.H., Mo J.H., Jin M.F., Wu S.L., Chen H.L. Expressions of polypeptide: N-acetylgalactosaminyltransferase in leukemia cell lines during 1,25-dihydroxyvitamin D3 induced differentiation. Glycoconj. J. 2006, 23:575-584.
37. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., Pasternack B.S. Clinical staging of chronic lymphocytic leukemia. Blood 1975, 46:219-234.
38. Rajpert-De Meyts E., et al. Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation. Virchows Arch. 2007, 451:805-814.
39. Shibao K., et al. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma. Cancer 2002, 94:1939-1946.
40. Stamatopoulos B., et al. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clin. Chem. 2007, 53:1757-1766.
41. Sutherlin M.E., et al. Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines. Cancer Res. 1997, 57:4744-4748.
42. Taniuchi K., et al. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene 2011, 30:4843-4854.
43. Ten Hagen K.G., Fritz T.A., Tabak L.A. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 2003, 13:1R-16R.
44. Tenno M., et al. Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity. Mol. Cell. Biol. 2007, 27:8783-8796.
45. Tollefsen S.E., Kornfeld R. The B4 lectin from Vicia villosa seeds interacts with N-acetylgalactosamine residues alpha-linked to serine or threonine residues in cell surface glycoproteins. J. Biol. Chem. 1983, 258:5172-5176.
46. Toscano M.A., et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007, 8:825-834.
47. Van Bockstaele F., et al. Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. Clin. Chem. 2007, 53:204-212.
48. van't Veer M.B., et al. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 2006, 91:56-63.
49. Vasconcelos Y., et al. Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia. J. Clin. Oncol. 2003, 21:3928-3932.
50. Wu C., et al. N-Acetylgalactosaminyltransferase 14, a novel insulin-like growth factor binding protein-3 binding partner. Biochem. Biophys. Res. Commun. 2007, 357:360-365.
51. Yamamoto S., et al. Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas. Pathobiology 2004, 71:12-18.